SNDL Inc

Aktienanalyse zu SNDL Inc (SNDL)

$1.410

+0.063 (+4.44%)Zum Schluss

Loading chart…
Hoch
1.430
Eröffnung
1.380
Volumengewichteter Durchschnittskurs
1.40
Volumen
1.71M
Marktkap.
507.43M
Tief
1.370
Umsatz
2.41M
EV/EBITDA, TTM
8.08

SNDL Inc., through its wholly owned subsidiaries, is a vertically integrated cannabis company and a private-sector liquor and cannabis retailer in Canada. Its retail banners include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds and Spiritleaf. With products available in licensed cannabis retail locations nationally, its consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Gron, No Future and Bhang Chocolate. Its liquor retail segment includes the sales of wines, beers and spirits. Its cannabis retail segment includes the sales of cannabis products and accessories through corporate-owned and franchised cannabis retail operations. Its cannabis operations segment operates as a licensed producer that grows cannabis using indoor facilities and manufactures cannabis products, providing cannabis processing services. Its investments segment includes deployment of capital to investment opportunities.

www.sndl.com

KI-Analyse of SNDL Inc (SNDL)

Halten

SNDL Inc is currently trading at $1.27, which is significantly below its 52-week high of $2.34, indicating potential upside. However, the company reported a widening net loss of C$7.8 million in Q2 2026 and a gross margin decline to 23.9%, which raises concerns about profitability. The RSI is at 49.95, suggesting the stock is neither overbought nor oversold, which may indicate a wait-and-see approach is prudent.

Bewertungskennzahlen

Das aktuelle erwartete KGV von SNDL Inc (SNDL) beträgt 91.74, verglichen mit dem 5-Jahres-Durchschnitt von 18.29.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
18.29
Aktuelles P/E
91.74
Überbewertet
144.59
Unterbewertet
-108.01

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-6.39
Aktuelles EV/EBITDA
8.08
Überbewertet
114.74
Unterbewertet
-127.53

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
0.85
Aktuelles P/S
0.41
Überbewertet
1.48
Unterbewertet
0.21

Alphio-AI-Kursszenarien für SNDL

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%SNDL

$1.55

Szenariopreis

B

Basis

Basis · 50%SNDL

$1.43

Szenariopreis

B

Bärisch

Bärisch · 25%SNDL

$1.23

Szenariopreis

Whales, die SNDL halten

A

Armistice Capital LLC

+ HältSNDL

-10.41%

3-Monats-Rendite

Event-Zeitleiste

2026-10-27 (ET)

07:30:00

SNDL Q3 Results Show Improvement in Financial Performance

2026-07-28 (ET)

07:31:00

SNDL Q2 Results Show Market Softness, Expected Annual Revenue Over $1B

2026-05-27 (ET)

18:40:00

SNDL Cancels Acquisition of Ontario Retail Locations

2026-04-29 (ET)

07:00:00

SNDL CEO Anticipates Improvement in Cannabis Market in H2 2026

2026-03-12 (ET)

07:00:00

SNDL Reports Q4 Revenue of $252.5M

News

SNDL FAQ – beantwortet von Alphio AI

SNDL Inc., through its wholly owned subsidiaries, is a vertically integrated cannabis company and a private-sector liquor and cannabis retailer in Canada. Its retail banners include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds and Spiritleaf. With products available in licensed cannabis retail locations nationally, its consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Gron, No Future and Bhang Chocolate. Its liquor retail segment includes the sales of wines, beers and spirits. Its cannabis retail segment includes the sales of cannabis products and accessories through corporate-owned and franchised cannabis retail operations. Its cannabis operations segment operates as a licensed producer that grows cannabis using indoor facilities and manufactures cannabis products, providing cannabis processing services. Its investments segment includes deployment of capital to investment opportunities. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

SNDL Inc is currently trading at $1.27, which is significantly below its 52-week high of $2.34, indicating potential upside. However, the company reported a widening net loss of C$7.8 million in Q2 2026 and a gross margin decline to 23.9%, which raises concerns about profitability. The RSI is at 49.95, suggesting the stock is neither overbought nor oversold, which may indicate a wait-and-see approach is prudent.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln